Abstract: Four ligands based on Chromene derivatives have been docked into integrase of prototype foamy virus, which has high structural similarity with that of HIV-1 integrase. The Autodock Vina (Vina) software was used for this purpose. The docking scores for the derivatives are -7.3 kcal/mol, -7.5 kcal/mol, -6.9 kcal/mol, and -7.2 kcal/mol, respectively, which are comparable with that for Raltegravir (-10.7 kcal/mol). The docking results provide a detailed evidence for the interactions of four Chromene derivatives. The results may lead to the design and development of new drug candidates against AIDS.
INTRODUCTION
The main reason of the acquired immunodeficiency syndrome (AIDS) is the human immunodeficiency virus type 1 (HIV-1). This is a progressive, sluggish and degenerative disease of the human immune system. HIV-1 belongs to the retrovirus family, which is classified as a lentivirus (1) . The HIV replication cycle involves the integration of viral DNA into the host chromosome, which is an essential process conducted by the viral integrase (IN) protein. This protein, together with reverse transcriptase and protease, is one of three enzymes encoded by HIV (2) . The current antiviral therapy for treatment of AIDS includes a combination therapy with reverse transcriptase and protease inhibitors with a potential therapeutic capability (3) . The integrase is a 32 kDa enzyme composed of three functional domains (catalytic core domain, an N-terminal domain and a less conserved C-terminal domain) (4, 5) . It does not have sequence homologue or an equivalent counterpart in the human host cell. Therefore, this makes the protein an attractive drug target (6) . There are few integrase inhibitors introduced as promising drug candidates for the treatment of AIDS after the authorization of Raltegravir (7) . Despite the effective activity of Raltegravir and several other inhibitors against anti-HIV integrase they possess adverse influences on prolonged usage and develop drug resistance. Thus, there is an urgent requirement to investigate new and potential chemical scaffolds for the treatment of AIDS.
Diketo acids (DKA) possess a metal-chelating function and they can simultaneously coordinate two divalent metal ions. Therefore, they are considered as potent inhibiting proteins which bear divalent metals which are involved in the hydrolysis of endonucleolytic phosphodiesters (8) (9) . Raltegravir is the first efficient anti-HIV drug targeting HIV-1 IN, which is classified as a diketo acid-based derivative. FDA approved it in October 2007. Besides, Elvitegravir is a monoketo acid derivative which has two functional groups with only one metal ion binding site. It is identified as a second integrase inhibitor approved in 2012 (10) (11) . (6) .
MATERIAL AND METHOD

Preparing of Receptor Structure
We obtained the crystallographic structure of full-length (3OYA.pdb) PFV Integrase from the Protein Data Bank (www.rcsb.org). This structure includes a DNA fragment and Raltegravir. After removing all ligands and water molecules from crystal structure, receptor and ligand files were separately saved by DS Visualizer software. MGL Tools (Version 1.5.7rc1) was used for creating pdbqt files of receptor and ligands needed for docking with Autodock Vina (Vina) (Version 1.1.2). Validation of docking method was performed by re-docking Raltegravir to the crystal structure. Binding mode of Raltegravir to the protein structure is shown in Fig. 2 which shows the ligand is located in a similar mode with its original location. 
Preparing of Ligand Structures
RESULTS AND DISCUSSION
On one hand, the prediction of some properties of molecules is important for their consideration as drug candidates. (Figure 3 ). All the ligands are placed in catalytic center of integrase and they all interact with both Mg ions. In L01, O11 and O20 atoms form electrostatic interactions with Mg ions while O5 atom forms a hydrogen bond with HN atom of DA17. Chromene ring of L01 also forms π-anion, π/CH interaction with Glu221, and Pro214, respectively (Figure 4 ). L02, which differs from L01 by lacking the double bond between C8 and C9 atoms of chromene, has a similar binding mode compared to that of L01 ( Figure 5 ). The binding role and importance of metal ions which are contained in the enzyme is well known (23). 
